CHLA researchers uncover a breakthrough biopsy method for retinoblastoma
Phoebe Harkin | | Interview
For Jesse Berry, discovering the suitability of aqueous humor as a biopsy site for retinoblastoma, was “serendipity.” A chance decision led Berry, Associate Director of Ocular Oncology at Children’s Hospital Los Angeles, to analyze the liquid inside a patient’s eye, and find it contained crucial genetic tumor information. The hope? That the novel liquid biopsy could open the door to more accurate diagnosis, more detailed understanding of treatment response, and more reliable prognosis.
We speak to Berry to find out how she made the discovery and why she is, in her words, “forever grateful.”
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine